THAR
Price:
$3.54
Market Cap:
$108.37M
Tharimmune, Inc. is a biotechnology firm operating in the clinical stage, focused on creating therapeutic solutions for rare, inflammatory, and oncological conditions. Its preclinical immuno-oncology portfolio includes several product candidates: TH104, aimed at treating inflammatory conditions linked to the liver and other causes of itching; TH3215 and TH0059, which are designed to address a variety of solid tumors; and TH1940, specifically targeting programmed cell death protein 1 (PD-1). Furthermore, the company has entered into a research collaboration and product license agreement with Minotaur Therapeutics, Inc. to develop proprietary targeted biologics. Originally incorporated in 2017...[Read more]
Industry
Biotechnology
IPO Date
2022-01-12
Stock Exchange
NASDAQ
Ticker
THAR
According to Tharimmune, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 66.84M. This represents a change of -63.45% compared to the average of 182.86M of the last 4 quarters.
The mean historical Enterprise Value of Tharimmune, Inc. over the last ten years is 26.10M. The current 66.84M Enterprise Value has changed 25.50% with respect to the historical average. Over the past ten years (40 quarters), THAR's Enterprise Value was at its highest in in the March 2026 quarter at 637.67M. The Enterprise Value was at its lowest in in the December 2023 quarter at -4955944.20.
Average
26.10M
Median
36.75M
Minimum
-10270450.44
Maximum
80.08M
Discovering the peaks and valleys of Tharimmune, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 389.28%
Maximum Annual Enterprise Value = 80.08M
Minimum Annual Increase = -8729.95%
Minimum Annual Enterprise Value = -10270450.44
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 80.08M | -8729.95% |
| 2024 | -927892.30 | -90.97% |
| 2023 | -10270450.44 | 389.28% |
| 2022 | -2099113.96 | -105.03% |
| 2021 | 41.71M | 11.27% |
| 2020 | 37.49M | 2.00% |
The current Enterprise Value of Tharimmune, Inc. (THAR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.96M
5-year avg
21.70M
10-year avg
26.10M
Tharimmune, Inc.’s Enterprise Value is greater than BioLineRx Ltd. (20.85M), greater than GeoVax Labs, Inc. (292.14K), less than Adlai Nortye Ltd. (550.38M), greater than Lunai Bioworks Inc. (9.18M), greater than SeaStar Medical Holding Corporation (-559927.00), greater than Adaptimmune Therapeutics plc (31.10M), greater than Ainos, Inc. (16.81M), greater than Apollomics, Inc. (13.15M), greater than Aditxt, Inc. (3.97M), greater than Moleculin Biotech, Inc. (3.96M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 20.85M | $14.66M | |
| 292.14K | $1.17M | |
| 550.38M | $547.79M | |
| 9.18M | $10.93M | |
| -559927.00 | $8.46M | |
| 31.10M | $75.16M | |
| 16.81M | $8.65M | |
| 13.15M | $15.78M | |
| 3.97M | $425.00 | |
| 3.96M | $14.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tharimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tharimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tharimmune, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tharimmune, Inc. (THAR)?
What is the 3-year average Enterprise Value for Tharimmune, Inc. (THAR)?
What is the 5-year average Enterprise Value for Tharimmune, Inc. (THAR)?
How does the current Enterprise Value for Tharimmune, Inc. (THAR) compare to its historical average?